NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Mumbai Investment: Nuvama Group's Private Equity Arm Invests ₹200 Crore in Val-Met Engineering

Mumbai, India - In a strategic move, the private equity arm of the Nuvama Group has invested ₹200 crore for a minority stake in Val-Met Engineering, a specialized supplier of aerospace and defence materials. This investment comes at a time when global manufacturers are increasingly shifting high-end production to India.

Val-Met Engineering's expertise in providing critical materials to the aerospace and defence sectors makes it an attractive target for investors seeking to tap into India's growing manufacturing capabilities. The investment by the Nuvama Group's private equity arm is expected to support Val-Met Engineering's expansion plans and further strengthen its position in the market.

CompanyInvestmentSector
Val-Met Engineering₹200 croreAerospace and Defence
Nuvama Group's Private Equity Arm--

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors may consider Nuvama Group's investment strategy in specialized suppliers.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.